ClinConnect ClinConnect Logo
Search / Trial NCT06114862

Brief Interventions on Social Media to Reduce Suicide Risk (Intervention 2)

Launched by HARVARD UNIVERSITY · Oct 30, 2023

Trial Information

Current as of July 22, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at ways to help reduce the risk of suicide among U.S. servicemembers and veterans by addressing the stigma around discussing mental health issues. Specifically, it will use the social media platform RallyPoint, which is designed for veterans to connect, to provide information on the benefits of sharing personal experiences related to mental health. The goal is to encourage more open conversations and decrease feelings of shame or fear that might prevent individuals from seeking help.

To participate in this trial, you need to be an active user of RallyPoint and have experienced symptoms of depression, anxiety, or thoughts about suicide in the past year. The trial is not currently recruiting participants yet, but once it does, those who qualify will take part in a program that offers helpful information and support. It's an opportunity to learn more about mental health in a supportive environment, and every participant's experience will contribute to better understanding how to help others who might be struggling.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Active RallyPoint users endorsing any symptoms of depression, anxiety, or suicidal thoughts and behaviors in the past year on a screener questionnaire will be eligible for this intervention.
  • Exclusion Criteria:
  • RallyPoint users denying depression, anxiety, or suicidal thoughts or behaviors in the past year in the screener survey.

About Harvard University

Harvard University, a prestigious Ivy League institution, is a leading sponsor of clinical trials, dedicated to advancing medical research and improving patient outcomes. With a strong emphasis on innovation and interdisciplinary collaboration, Harvard leverages its world-class faculty, cutting-edge facilities, and extensive resources to conduct rigorous clinical studies across various fields, including medicine, public health, and biomedical sciences. The university is committed to adhering to the highest ethical standards and regulatory guidelines, ensuring the safety and well-being of participants while contributing valuable insights to the global healthcare community. Through its clinical research initiatives, Harvard aims to translate scientific discoveries into effective treatments and preventive strategies that address pressing health challenges.

Locations

Boston, Massachusetts, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported